Dr. Bram is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Hematology/Oncology, 1989 - 1993
- Stanford Health Care-Sponsored Stanford UniversityResidency, Pediatrics, 1987 - 1989
- Stanford University School of MedicineClass of 1987
Certifications & Licensure
- CA State Medical License 1988 - Present
- MN State Medical License 1998 - 2025
- TN State Medical License 1994 - 1999
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2002
Clinical Trials
- Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors Start of enrollment: 2015 Jun 21
Publications & Presentations
PubMed
- 1 citationsAccelerated Aging in Cyclophilin B-Deficient Mice Downstream of p21-Cip1/Waf1.Ying Zhang, Robert J Pignolo, Richard J Bram
JBMR Plus. 2022-10-01 - Early expression of mature αβ TCR in CD4CD8T cell progenitors enables MHC to drive development of T-ALL bearing NOTCH mutations.Kimberly G Laffey, Robert J Stiles, Melissa J Ludescher, Tessa R Davis, Shariq S Khwaja
Proceedings of the National Academy of Sciences of the United States of America. 2022-07-05 - 15 citationsPhase I trial of sargramostim/pelareorep therapy in pediatric patients with recurrent or refractory high-grade brain tumors.Matthew R Schuelke, Justin H Gundelach, Matt Coffey, Emma West, Karen Scott
Neuro-Oncology Advances. 2022-06-17
Press Mentions
- A Golden Age for Pediatric CardiologyFebruary 2nd, 2017
Grant Support
- Cyclophilin B As A Therapeutic Target In GlioblastomaNational Institute Of Neurological Disorders And Stroke2011
- CAML In T Cell Development And FunctionNational Institute Of Allergy And Infectious Diseases2008–2011
- CAML In Normal And Oncogenic Functions Of The EGFRNational Cancer Institute2005–2009
- Calcium Modulating Cyclophilin Ligand In Normal &Oncogenic Functions Of The EGFRNational Cancer Institute2007–2008
- CAML In T Cell Development And FunctionNational Institute Of Allergy And Infectious Diseases2007
- Role Of TACI In B Cell Function And TransformationNational Cancer Institute2004–2007
- Role Of Cadml In Embryonic And Lymphocyte DevelopmentNational Cancer Institute2004
- Role Of TACI In B Cell Function And TransformationNational Cancer Institute2003
- Role Of Cadml In Embryonic And Lymphocyte DevelopmentNational Cancer Institute2000–2003
- TACI And B Cell Function And TransformationNational Cancer Institute1999–2002
- Core--Cell Microinjection Shared ResourceNational Cancer Institute1997–2002
- TACI And B Cell Function And TransformationNational Cancer Institute1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: